Skin cancer combination therapy one step closer to EU approval
Skin cancer combination therapy one step closer to EU approval
25 Sep 2015Roche is expecting the European Commission this year to issue a final decision on a drug combination to treat advanced skin cancer, based on the positive opinion issued on the product.
The European Union's Committee for Medicinal Products for Human Use, or CHMP, has adopted a positive opinion for Cotellic, when used in combination with Zelboraf for treatment of patients with a type of metastatic melanoma, Roche declared.
Roche in August won approval for the drug combination in Switzerland and expects a final decision on approval in the United States this year.
Source: Reuters